The use of fibrinogen concentrate in coagulation testing aids in the diagnosis and management of rare bleeding disorders
Transfusion Medicine · 28.04.2026
DOI: 10.1111/tme.70085 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion Medicine, online erschienen am 28.04.2026. Verfasst von Yang Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Hubei Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Many clinical laboratories lack the methods or resources to quickly identify rare haemorrhagic diseases, such as genetic/acquired fibrinogen defects and factor XIII deficiency. Case Report This report explored the value of human fibrinogen concentrate in the diagnosis and management of rare bleeding disorders through three case studies. Case 1 involved acquired hypofibrinogenemia caused by snake bite, where the coagulation abnormality was corrected by adding fibrinogen in vitro, confirming the mechanism of snake venom‐specific degradation of fibrinogen. Case 2 utilised fibrinogen solution to establish a thromboelastography mixing test for rapid diagnosis of autoimmune factor XIII inhibitors. Case 3 improved platelet aggregation function in patients with congenital abnormal fibrinogenaemia through fibrinogen solution.
Conclusion
These case studies showed that fibrinogen concentrate may serve as a specific additive to assist in the rapid identification of coagulation dysfunction and guide precise treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Hematology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
- Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Förderung
- Hubei Provincial Natural Science Foundation of China
Zitieren
APA
Yang, Y., Zhang, L., Lei, Z., & Tang, N. (2026). The use of fibrinogen concentrate in coagulation testing aids in the diagnosis and management of rare bleeding disorders. Transfusion Medicine. https://doi.org/10.1111/tme.70085
Vancouver
Yang Y, Zhang L, Lei Z, Tang N. The use of fibrinogen concentrate in coagulation testing aids in the diagnosis and management of rare bleeding disorders. Transfusion Medicine. 2026. doi:10.1111/tme.70085
BibTeX
@article{Yang2026,
author = {Yang, Yang and Zhang, Lulu and Lei, Zekai and Tang, Ning},
title = {The use of fibrinogen concentrate in coagulation testing aids in the diagnosis and management of rare bleeding disorders},
journal = {Transfusion Medicine},
year = {2026},
doi = {10.1111/tme.70085}
}
EUVIMED